Novartis Puts Down $50m For Mesoblast COVID-19 Cell Therapy

Reversal Of Fortunes For Remestemcel-L

Rescue
Novartis comes to Mesoblast's rescue • Source: Shutterstock

More from COVID-19

More from Scrip